scout
|Videos|May 21, 2016

Impact of Biosimilars on Oncology

Author(s)Sue Naeyaert,

Sue Naeyaert, senior director of Biosimilars Policy, EMD Serono, discusses the long-term impact that biosimilars could potentially have on the field of oncology.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME